Literature DB >> 7660407

US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices.

L B Goldstein1, A J Bonito, D B Matchar, P W Duncan, G H DeFriese, E Z Oddone, J E Paul, D R Akin, G P Samsa.   

Abstract

BACKGROUND AND
PURPOSE: Stroke is largely a preventable disease. However, there are little data available concerning the use of stroke prevention diagnostic and treatment modalities by practicing physicians. These data are critical for the rational allocation of resources and targeting of educational efforts. The purposes of this national survey were to gather information about physicians' stroke prevention practice patterns and their attitudes and beliefs regarding secondary and tertiary stroke prevention strategies.
METHODS: We conducted a national survey of stroke prevention practices among a stratified random sample of 2000 physicians drawn from the American Medical Association's Physician Masterfile. The survey focused on the availability of services and the use of diagnostic and preventive strategies for patients at elevated risk of stroke.
RESULTS: Sixty-seven percent (n = 1006) of eligible physicians completed the survey. Diagnostic studies considered readily available by at least 90% of physicians included carotid ultrasonography, transthoracic echocardiography, Holter monitoring, and brain CT and MRI scans. MR angiography was perceived as being readily available by 68% and transesophageal echocardiography by 74% of respondents. Twelve percent of physicians reported cerebral arteriography and 10% reported carotid endarterectomy as not being readily available. Multiple logistic regression analyses showed that the availability of services varied with physician specialty (noninternist primary care, internal medicine, neurology, surgery), practice setting (nonmetropolitan versus small metropolitan or large metropolitan areas), and for carotid endarterectomy, region of the country (South, Central, Northeast, and West). The odds of carotid endarterectomy being reported as readily available were approximately 2.5 to 3.5 times greater for physicians practicing in the central, northeastern, and western regions compared with those practicing in the South, independent of practice setting and specialty. With regard to stroke prevention practices, 61% of physicians reported prescribing 325 mg of aspirin for stroke prevention, while 33% recommend less than 325 mg and 4% use doses of 650 mg or more. Seventy-one percent of physicians using warfarin reported monitoring anticoagulation with international normalized ratios, and 78% reported monitoring anticoagulated patients at least once a month. Fewer than 20% of physicians reported knowing the perioperative carotid endarterectomy complication rates at the hospital where they perform the operation themselves or refer patients to have the procedure done.
CONCLUSIONS: Although all routine and most specialized services for secondary and tertiary stroke prevention are readily available to most physicians, variation in availability exists. The use of international normalized ratios for monitoring warfarin therapy has not yet become universal. Physician knowledge of carotid endarterectomy complication rates is generally lacking. Depending on their causes, these problems may be addressed through targeted physician education efforts and systematic changes in the way in which services are provided.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660407     DOI: 10.1161/01.str.26.9.1607

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Clinical decision support systems for the practice of evidence-based medicine.

Authors:  I Sim; P Gorman; R A Greenes; R B Haynes; B Kaplan; H Lehmann; P C Tang
Journal:  J Am Med Inform Assoc       Date:  2001 Nov-Dec       Impact factor: 4.497

2.  Characterizing early prescribers of newly marketed drugs in Canada: a population-based study.

Authors:  Anita Kozyrskyj; Colette Raymond; Amber Racher
Journal:  Eur J Clin Pharmacol       Date:  2007-03-23       Impact factor: 2.953

Review 3.  Place of drug therapy in the treatment of carotid stenosis.

Authors:  Norberto Andaluz; Mario Zuccarello
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.

Authors:  Eugene D Kaplan; Ralph L Sacco
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

5.  Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.

Authors:  Tanya N Turan; George Cotsonis; Michael J Lynn; Rahim H Wooley; Seegar Swanson; Janice E Williams; Barney J Stern; Colin P Derdeyn; David Fiorella; Marc I Chimowitz
Journal:  Cerebrovasc Dis       Date:  2014-02-19       Impact factor: 2.762

6.  Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?

Authors:  Kevin Fiscella; Paul C Winters; Michael Mendoza; Gary J Noronha; Carlos M Swanger; John D Bisognano; Robert J Fortuna
Journal:  J Gen Intern Med       Date:  2015-02       Impact factor: 5.128

7.  Primary prevention of first-ever stroke in primary health care: a clinical practice study based on medical register data in sweden.

Authors:  Ylva Skånér; Gunnar H Nilsson; Ingvar Krakau; Ejda Hassler; Kristina Sundquist
Journal:  Stroke Res Treat       Date:  2010-07-11

Review 8.  Risk factor management to prevent first stroke.

Authors:  Tatjana Rundek; Ralph L Sacco
Journal:  Neurol Clin       Date:  2008-11       Impact factor: 3.806

9.  Specialty training and specialization among physicians who treat HIV/AIDS in the United States.

Authors:  Bruce E Landon; Ira B Wilson; Neil S Wenger; Susan E Cohn; Carl J Fichtenbaum; Samuel A Bozzette; Martin F Shapiro; Paul D Cleary
Journal:  J Gen Intern Med       Date:  2002-01       Impact factor: 5.128

10.  Trends in Ambulatory Prescribing of Antiplatelet Therapy among US Ischemic Stroke Patients: 2000-2007.

Authors:  Sudeep Karve; Deborah Levine; Eric Seiber; Milap Nahata; Rajesh Balkrishnan
Journal:  Adv Pharmacol Sci       Date:  2012-12-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.